Скачать или смотреть BioPharma CVC 2025 Trends: Bold Bets & Where Investment Is Flowing

In this fast snapshot from LucidQuest, discover the top corporate venture players, the hottest technologies, and the therapeutic areas that are shaping the next wave of deals. 🚀

What you will learn, quickly:

Leaders 🚀
Google Ventures tops portfolio count with 60+ investments 📊, while AbbVie drives the most strategic exits 🔑

Tech focus 💻⚗️🧬🤖
Small Molecule Therapeutics 💊, Gene Therapy 🧬, and Digital + AI 🤖 lead the pack, with antibody platforms 🧫 and machine learning 🧠 accelerating across CVCs

Therapeutic momentum 🩺
Oncology 🎗️ still dominates, immune disorders 🛡️ are rising since 2023, while allergy 🤧, neurodegeneration 🧠, and pain 💥 remain niche but growing

Diversification 🌐
GV, Eli Lilly 💉, and Sanofi 💊 appear across multiple CVC portfolios 📂, signaling cross-strategy relevance 🔄

Emerging plays 🌱
Amgen 🎯 tilts to Cell & Gene Therapy 🧬, M Ventures and GV lean into Digital + AI 🤖, while Regeneron’s new fund 🎯 targets gene therapy & oncology 🧬🎗️

Why it matters:
Where tech-enabled biology meets de-risked modalities is where the next set of breakout BioPharma deals will likely emerge. If you are scouting partnerships, building a pipeline, or raising a round, this overview will sharpen your map.

📊 Acess the full Report 📥 https://bit.ly/46zutfv
📢 Stay Ahead in BioPharma CVC trends!
✅ Like, share, and subscribe for future updates on healthcare venture insights
✅ Visit www.lqventures.com for expert healthcare insights and consulting services.
✅ Contact LucidQuest at [email protected] for strategic insights on BioPharma venture strategy and partnerships
🔔 Turn on notifications so you never miss an update!

#Biopharma #CVC #VentureCapital #PharmaInnovation #GeneTherapy #DigitalHealth #AIinHealthcare #Oncology #DrugDiscovery #HealthcareInvesting #GoogleVentures #AbbVie #EliLilly #Sanofi #Amgen #MVentures #Regeneron #CVC #VentureCapital #Biotech #DigitalHealth #GeneTherapy #Oncology #Immunology #Innovation #LifeSciences